December 1999
We made a groundbreaking contribution to global health by developing a next-generation vaccine for Hepatitis B & C.
Hepatitis B and C are viral infections that affect the liver and can lead to serious complications such as cirrhosis and liver cancer. At Biotech, we’ve developed vaccines and therapies aimed at preventing and treating these chronic infections.
March 2004
Epidermolysis Bullosa – Protecting the Skin from Within.
Epidermolysis Bullosa, also known as “butterfly skin disease,” causes severe skin blistering and painful wounds. Biotech has developed a vaccine aimed at improving skin integrity and reducing blister formation. Our treatment works by stimulating the body’s healing response, offering hope to those affected by this debilitating genetic disorder..
April 2010
Spinal Muscular Atrophy (SMA) – Strengthening the Body’s Defenses.
Spinal Muscular Atrophy is a genetic condition that causes muscle wasting and progressive weakness. At Biotech, we have developed a vaccine that targets the defective genes responsible for SMA, potentially halting or even reversing muscle degeneration. Through innovative research and clinical trials, we hope to offer SMA patients a new path to strength and independence..
May 2019
Sickle Cell Disease – New Hope for Blood Disorders
Sickle cell disease causes painful crises and organ damage due to abnormal red blood cells. Biotech has developed a groundbreaking vaccine that aims to address the underlying genetic causes of the disease. Our vaccine works by improving the production of healthy red blood cells and reducing the severity of symptoms, offering patients a better quality of life..
